GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CT
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowOn March 23, 2026, GE HealthCare Technologies Inc. (GEHC) obtained FDA 510(k) clearance for its Photonova Spectra, a next-generation photon-counting CT system. This system features Deep Silicon detector technology, which provides higher spatial and spectral resolution compared to conventional models. It can process data volumes up to 50 times greater than standard CT systems, supporting efficient workflows. Following this clearance, GEHC is preparing for full commercial availability in the U.S. market, addressing the increasing diagnostic demand.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About GE HealthCare Technologies (GEHC)
GE HealthCare makes medical-imaging and diagnostic equipment.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
GEHC stock page and all news βGet the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
